Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2005 Jan;20(1):139–144. doi: 10.1007/BF02893060

Cystatin C—A novel marker of glomerular filtration rate: A review

Purnima Dey Sarkar 1,✉, G Rajeshwari 2, T M Shivaprakash 3
PMCID: PMC3454169  PMID: 23105512

Abstract

Glomerular filtration rate is routinely assessed by measuring the serum markers such as urea nitrogen and serum creatinine. Although these markers are widely used to assess renal function but they do not perform optimally in certain clinical settings. There is thus a practical need for an easily automated alternative to plasma creatine, which would be more specific, sensitive and reliable from the analytical and clinical view point. Compared with the above endogenous markers, and time consuming laborious tests, Cystatin C facilitates the recognition of abnormal renal function in children, as its reference range is constant beyond the 1st year of life. This review mainly focuses on the diagnostic performance of Cystatin C against other renal markers in the pediatric population and in specific subpopulations of patients.

Key Words: Cys C—cystatin C, Scr—Serum creatinine, GFR—Glomerular Filtration Rate, ROC—Receiver, Operating Curve, Crcl-Creatinine clearance

Full Text

The Full Text of this article is available as a PDF (571.9 KB).

References

  • 1.Heymsfield SB, Arteaga C, Maccanus C, Smith J, Moffitt S. Measurement of muscle mass in humans: Validity of the 24 hour uninary creatinine method. Am. J. Clin. Nuctr. 1983;37:478–94. doi: 10.1093/ajcn/37.3.478. [DOI] [PubMed] [Google Scholar]
  • 2.Newman DJ, Price CP. Renal functions and nitrogen metabolites. In: Burtis CA, Ash Wood ER, editors. Tietz text book of clinical chemistry. Philadelphia: WB Saunders; 1999. pp. 1204–70. [Google Scholar]
  • 3.James GD, Sealey JE, Alderman M, Tungmans L., Mueller FB, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, Sex and age differences. Am. J. Hypertens. 1988;1:124–31. doi: 10.1093/ajh/1.2.124. [DOI] [PubMed] [Google Scholar]
  • 4.Leyey AS, Berg RL, Gassman TT, Hall PM, Walker WG. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int. 1989;36(Suppl 27):373–80. [PubMed] [Google Scholar]
  • 5.Perrone RD, Madias NE, Levey AS. Serum creatinine as an Index of renal function: new insights into old concepts. Clin. Chem. 1992;38:1933–53. [PubMed] [Google Scholar]
  • 6.Swan SK. The search continues—an ideal marker for GFR. Clin. Chem. 1997;43:913–4. [PubMed] [Google Scholar]
  • 7.Haycock GB. Creatinine, body size and renal function. Pediatr Nephrol. 1989;3:22–24. doi: 10.1007/BF00859619. [DOI] [PubMed] [Google Scholar]
  • 8.Grubb AO. Cystatin C-properties and use as a diagnostic marker. Adv Clin. Chem. 2000;35:63–99. doi: 10.1016/S0065-2423(01)35015-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Harmoinen Aimo, Ylinen Elisa, et al. Reference intervals for cystatin C in pre and full term infants and children. Pediatr. Nephrol. 2000;15:105–108. doi: 10.1007/s004670000421. [DOI] [PubMed] [Google Scholar]
  • 10.Abrahamson M, Olafsson I, Plasdottir A, Ulvsback M, Lund Wall A, Tensson O, et al. Structure and expression of the human cystatin C gene. Biochem J. 1990;268:287–94. doi: 10.1042/bj2680287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 1992;38:520–7. [PubMed] [Google Scholar]
  • 12.Lofberg H., Grubb A.O. Quantification of gamma-trace in human biological fluids. Indication for production in the central nervous system. Scand. J. Clin. Lab invest. 1979;39:619–26. doi: 10.3109/00365517909108866. [DOI] [PubMed] [Google Scholar]
  • 13.Poulik Perry, Vokec, et al. Post-gamma globulin N. Radioimmunoassay determination of levels of post gamma globulin and b2 microglobulin. Clin. Chem. Acta. 1983;128:249–60. doi: 10.1016/0009-8981(83)90325-X. [DOI] [PubMed] [Google Scholar]
  • 14.Ishiguro H, Ohkubo I, Mizo Kami M, et al. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma. 1989;8:303–13. doi: 10.1089/hyb.1989.8.303. [DOI] [PubMed] [Google Scholar]
  • 15.Colle A, Tavera C, Prevot D, et al. Cystatin C levels in sera of patients with human immuno deficiency virus infection. A new avidin-biotin ELISA assay for its measurement. J. Immuno assay. 1992;13:47–60. doi: 10.1080/15321819208019824. [DOI] [PubMed] [Google Scholar]
  • 16.Erlandsen EJ, Randers E, Krishten sen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin. Chem.. lab Med. 1998;36:393–7. doi: 10.1515/CCLM.1998.067. [DOI] [PubMed] [Google Scholar]
  • 17.Norlund L, Fex G, Lanke J, Schenck H, Nilsson JE, et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: Serum Cystatin C and serum b2 mcro globulin / cystatin C ratio. Scand. J. Clin. Lab. Invest. 1997;57:463–70. doi: 10.3109/00365519709084595. [DOI] [PubMed] [Google Scholar]
  • 18.Kyhse-Andersen J., Schmidt C, Nordin G, Anderson B., Ehle Nilsson, et al. Serum Cstatin C, determined by a rapid, automated particle-enhanced turbidometric method is a better marker than serum creatinine for glomerular filtration rate. Clin. chem. 1994;40:1921–6. [PubMed] [Google Scholar]
  • 19.Pergande M, Jung K. Sandwich enzyme immuno assay of cystatin C in serum with commercially available anti bodies. Clin chem. 1993;39:1885–90. [PubMed] [Google Scholar]
  • 20.Uhlmann E, Hock KG, Issitt C, Sneeringer MR, et al. Reference intervals for plasma cystatin C in healthy volunteers and renal patients as measured by the Dade Behring BN II System, and correlation with creatinine. Clin. chem. 2001;47:2031–3. [PubMed] [Google Scholar]
  • 21.Price C, Finney H. Developmets in the assessments of glomerular filtration rate. Clin. chem. Acta. 2000;297:55–66. doi: 10.1016/S0009-8981(00)00233-3. [DOI] [PubMed] [Google Scholar]
  • 22.Finney H, Baes CJ, Price CP. Plasma cystatin C determinations in a healthy elderly population. Arch. Gerontol. Geriatr. 1999;29:75–94. doi: 10.1016/S0167-4943(99)00025-4. [DOI] [PubMed] [Google Scholar]
  • 23.Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb A, Price CP. Serum cystatin C measured by automated immuno assay: a more sensitive marker of changes in GFR than serum Creatinine. Kidney Int. 1995;45:312–318. doi: 10.1038/ki.1995.40. [DOI] [PubMed] [Google Scholar]
  • 24.Zweing MH, Cambel G. Reciver operating charteristic (ROC) plots; a fundamental evaluation tool in clinical medicine. Clin chem. 1993;39:561–577. [PubMed] [Google Scholar]
  • 25.Sweets JA. measuring the accuracy of diagnostic systems. Science. 1988;240:1285–1293. doi: 10.1126/science.3287615. [DOI] [PubMed] [Google Scholar]
  • 26.Bokenkamp Arend, Domanetzki Michael, Zinck Raymund, Schumann Genhard, Brodehl Johannes. Reference values for cystatin C serum concentrations in children. Pediatric Nephrology. 1998;12:125–129. doi: 10.1007/s004670050419. [DOI] [PubMed] [Google Scholar]
  • 27.Grubb A, Simonsen O, Stuflet G, Truedsson L, Thysell H. Serum concentration of cysc, b micro globulin as a measure of glomerular filtration rate. Acta. Med Scand. 1985;218:499–503. doi: 10.1111/j.0954-6820.1985.tb08880.x. [DOI] [PubMed] [Google Scholar]
  • 28.Helin I, Axenram M, Grubb Serum cystatin C as a determinant of glomerular filtration rate in children. Clin. Nephrol. 1998;49:221–225. [PubMed] [Google Scholar]
  • 29.Bokenkamp A., Domanet Ki M., Zimck R, Schumann G., Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–881. doi: 10.1542/peds.101.5.875. [DOI] [PubMed] [Google Scholar]
  • 30.Elisa A, Linen Y, Ala-Houhala Marja, Almo PT, Harmonen, et al. Cystatin C as a marker for glomerular filtration rate in pediatric patients. Pediatr Nephrol. 1999;13:506–509. doi: 10.1007/s004670050647. [DOI] [PubMed] [Google Scholar]
  • 31.Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am. J. Kidney Dis. 1982;2:337–346. doi: 10.1016/s0272-6386(82)80091-7. [DOI] [PubMed] [Google Scholar]
  • 32.Harmoinen APT, Kouri TT, Wirta OR, Rantalaiho V, et al. Evaluation of plasma cystatin C as a marker for glomemlar filtration rate in patients with type 2 diatetes. Clin Nephrol. 1999;52:363–370. [PubMed] [Google Scholar]
  • 33.Keevil BG, Kilpatric ES. Biological Variation of cystatin C: Implicatios for the assessment of glomemlar filtration rate. Clin chem. 1998;44:1535–1539. [PubMed] [Google Scholar]
  • 34.Filler G, Witt I, Priem F, Ehrich JHH, Jung K. Are cystatatin C and b2-microglobulin better markers than serum creatinine for prediction of a normalglomerular filtration rate in pediatrics. Clin. Chem. 1997;43:1077–78. [PubMed] [Google Scholar]
  • 35.Knapp ML, Mayne PD. Development of an automated Kinetic Jaffe’s method designed to minimize bilirubin interference in plasma creatinine assays. Clin. Chem Acta. 1987;168:239–246. doi: 10.1016/0009-8981(87)90293-2. [DOI] [PubMed] [Google Scholar]
  • 36.Kairisto V, poola A. software for illustrative presentation f basic clinical characteristics of laboratory tests Graph ROC for windows. Scand J Clin. Lab invest. 1995;55(suppl 222):43–60. doi: 10.3109/00365519509088450. [DOI] [PubMed] [Google Scholar]
  • 37.Amino harmoinen, Elisa Ylinen et al (2000). Reference intervals for cystatin C in pre and full tern infants and children.Pediatr Nephrol;105–108 [DOI] [PubMed]
  • 38.Randers E, Krue S, Erlandsen EJ, Danielsen H, Hansen LG. Reference interval for serum cystatin C in children. Clin chem. 1999;45:1856–8. [PubMed] [Google Scholar]
  • 39.Filler G, Witt I, Priem F, Ehrich JHH, Jung K. Are cystatin C and b microglobulin better markers than serum cratinine for prediction of a normal glomerular filtration rate in pediatric subjects. Clin chem. 1997;43:1077–8. [PubMed] [Google Scholar]
  • 40.Bokengamp A, Domentz Ki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–81. doi: 10.1542/peds.101.5.875. [DOI] [PubMed] [Google Scholar]
  • 41.Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol. 1998;49:221–5. [PubMed] [Google Scholar]
  • 42.Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Koun T. Reference intervals for cystatin C in pre and full term infants and children. pediatr. Nephrol. 2000;15:105–8. doi: 10.1007/s004670000421. [DOI] [PubMed] [Google Scholar]
  • 43.Finny H, Newman DJ, Thakkar H, Fell JME, Price CD. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates and older children. Arch. Dis Child. 2000;82:71–5. doi: 10.1136/adc.82.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Montini G, Amici G, Zacchello G. Plasma cystatin C values and inulin clearances in premature neonates (Letter) Pediatr. Nephrol. 2000;16:463–4. doi: 10.1007/s004670100592. [DOI] [PubMed] [Google Scholar]
  • 45.Ylinen EA, Ala-Houhala M, Harmoinen AP, Knip M. Cystatin C as a marker for glomerular filtration rate in pediatric patients. Pediatr. Nephrol. 1999;13:506–9. doi: 10.1007/s004670050647. [DOI] [PubMed] [Google Scholar]
  • 46.Patterson WP, Reams GP. Renal toxicities of chemotherapy. Semin Oncol. 1992;19:521–8. [PubMed] [Google Scholar]
  • 47.Stabuc B, Vrhovec L, Stabuc Silih M, Cizej TE. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin chem. 2000;46:193–7. [PubMed] [Google Scholar]
  • 48.Bricon T, Thervet E, Benlakechal M, et al. Changes in plasma cystatin C after renal transplanatation and acute rejection in adults. Clin chem. 1999;45:2243–9. [PubMed] [Google Scholar]
  • 49.Halimi S, Zmirou D, Benhamou PY, et al. Huge progression of diabetes prevalence and invidence among dialyzed patients in mainland France and overseas territories. A second national survey six year apart. Diabetes Metab. 1999;25:507–512. [PubMed] [Google Scholar]
  • 50.Viberti GC, Jarrett RJ, Mahmud U, et al. Micro albuminuria as a predictor of clinical nephropathy in insulin department diabetes mellitus. Lancet. 1982;1:1430–1432. doi: 10.1016/S0140-6736(82)92450-3. [DOI] [PubMed] [Google Scholar]
  • 51.Mogensen CE. Micro albuminuria, blood pressure and diabetic renal disease: Origins and development of ideas. Diabetologia. 1999;42:263–285. doi: 10.1007/s001250051151. [DOI] [PubMed] [Google Scholar]
  • 52.Bahmen P, Tabaei BP, Al-Kasab AS, et al. Does micro albuminuria predict nephropathy. Diabetes care. 2001;24:1560–1566. doi: 10.2337/diacare.24.9.1560. [DOI] [PubMed] [Google Scholar]
  • 53.Caroline perlemonie, Marie-Christine bequvieux Vincent Rigalleau et al. Interest of cystatin C in screening diabetic patients for early impairment of Renal function. Metabolism. 2003;52:1258–1264. doi: 10.1016/S0026-0495(03)00193-8. [DOI] [PubMed] [Google Scholar]
  • 54.Buysschaert M, Joudi I, et al. Comparative performance of serum cystatin C versus serum creatinine in idagetic subjects. Diabetes Metab. 2003;29:377–83. doi: 10.1016/S1262-3636(07)70048-4. [DOI] [PubMed] [Google Scholar]
  • 55.Shimizu A, Horikoshi S, Rinno H, Kobata M, et al. Serum cystatin C may predict early prognostic stages of patients with type 2 diabetic nephropathy. J. Clin Lab Anal. 2003;17:164–7. doi: 10.1002/jcla.10087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Fricker M, Wiesli P, Brandle M, et al. Impact of thyroid dysfunction on serum cystatin C. Kidney int. 2003;63:1994–7. doi: 10.1046/j.1523-1755.2003.00925.x. [DOI] [PubMed] [Google Scholar]
  • 57.Strevens Helena, Grubb Anders, Hanse Alastair, et al. Serum Cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre—eclamptic pregnancies.Int journal of obstet. Gynae. 2003;110:825–830. [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES